BADEMLER, S. Et Al. 2018. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer. Acta Medica Mediterranea , vol.34, no.6 , 2055-2060.

BADEMLER, S., Sari, M., Üçüncü, M. Z., SERİLMEZ, M., & Karabulut, S., (2018). Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer. Acta Medica Mediterranea , vol.34, no.6, 2055-2060.

BADEMLER, Süleyman Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer," Acta Medica Mediterranea , vol.34, no.6, 2055-2060, 2018

BADEMLER, Süleyman Et Al. "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer." Acta Medica Mediterranea , vol.34, no.6, pp.2055-2060, 2018

BADEMLER, S. Et Al. (2018) . "Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer." Acta Medica Mediterranea , vol.34, no.6, pp.2055-2060.

@article{article, author={Süleyman BADEMLER Et Al. }, title={Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth binding protein-3 (IGFBP-3) in patients with gastric cancer}, journal={Acta Medica Mediterranea}, year=2018, pages={2055-2060} }